Axon Neuroscience Appoints Michal Fresser as Group CEO

LARNACA, Cyprus, Aug. 1, 2019 -- (Healthcare Sales & Marketing Network) -- AXON NEUROSCIENCE SE, a global leader in the development of tau-immunotherapies and diagnostics for Alzheimer's disease and other tauopathies, today announces the appointment of Mi... Biopharmaceuticals, Neurology, Personnel Axon Neuroscience, tau immunotherapy, immunotherapy, Alzheimer's disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news